Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas
Yazan F Madanat,1 Mitchell R Smith,2 Alexandru Almasan,3 Brian T Hill2 1Department of Internal Medicine, 2Department of Hematology and Medical Oncology, Taussig Cancer Institute, 3Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA Abstract: Chronic lymphoc...
Guardado en:
Autores principales: | Madanat YF, Smith MR, Almasan A, Hill BT |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/89d8c5e4fe2c4f3693441581fda438cc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of obinutuzumab alone and in combination for follicular lymphoma
por: Sarraf Yazdy M, et al.
Publicado: (2017) -
CASE REPORT: FOLLICULAR LYMPHOMA PRESENTED WITH CHYLOTHORAX
por: Senem MARAL, et al.
Publicado: (2021) -
Targeting CD20 in chronic lymphocytic leukemia
por: Nahas MR, et al.
Publicado: (2015) -
The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
por: Schieber M, et al.
Publicado: (2019) -
The expanding role of bendamustine in chronic lymphocytic leukemia
por: Nair KS, et al.
Publicado: (2015)